Document is current

Article History

Received: 19 September 2024

Revised: 2 April 2025

Accepted: 3 April 2025

First Online: 20 May 2025

Competing interests

: Dr. Vizer reports no financial relationships with commercial interests. Dr. Pierce receives support from the National Institute of Mental Health, K01 MH126079. Ms. Ji reports no financial relationships with commercial interests. Dr. Bucher reports no financial relationships with commercial interests. Dr. Liu reports no financial relationships with commercial interests. Dr. Ungar reports no financial relationships with commercial interests. Dr. Giorgi reports no financial relationships with commercial interests. Dr. Xing reports no financial relationships with commercial interests. Dr. House reports no financial relationships with commercial interests. Dr. Beaudoin reports no financial relationships with commercial interests. Dr. Stevens reports no financial relationships with commercial interests. Dr. Neylan has received research support from NIH, VA, and Rainwater Charitable Foundation, and consulting income from Jazz Pharmaceuticals. In the last three years Dr Clifford has received research funding from the NSF, NIH and LifeBell AI, and unrestricted donations from AliveCor Inc, Amazon Research, the Center for Discovery, the Gates Foundation, Google, the Gordon and Betty Moore Foundation, MathWorks, Microsoft Research, Nextsense Inc, One Mind Foundation, and the Rett Research Foundation. Dr Clifford has financial interest in AliveCor Inc and Nextsense Inc. He also is the CTO of MindChild Medical with significant stock. These relationships are unconnected to the current work. Dr. Jovanovic receives support from the National Institute of Mental Health, R01 MH129495. Dr. Linnstaedt reports no financial relationships with commercial interests. Dr. Germine receives funding from the National Institute of Mental Health (R01 MH121617) and is on the board of the Many Brains Project. Her family also has equity in Intelerad Medical Systems, Inc. Dr. Bollen reports no financial relationships with commercial interests. Dr. Rauch reported serving as secretary of the Society of Biological Psychiatry; serving as a board member of Community Psychiatry and Mindpath Health; serving as a board member of National Association of Behavioral Healthcare; serving as secretary and a board member for the Anxiety and Depression Association of America; serving as a board member of the National Network of Depression Centers; receiving royalties from Oxford University Press, American Psychiatric Publishing Inc, and Springer Publishing; and receiving personal fees from the Society of Biological Psychiatry, Community Psychiatry and Mindpath Health, and National Association of Behavioral Healthcare outside the submitted work. Dr. Haran reports no financial relationships with commercial interests. Dr. Storrow reports no financial relationships with commercial interests. Dr. Lewandowski reports no financial relationships with commercial interests. Dr. Musey reports no financial relationships with commercial interests. Dr. Hendry reports no financial relationships with commercial interests. Dr. Sheikh reports no financial relationships with commercial interests. Dr. Jones has no competing interests related to this work, though he has been an investigator on studies funded by AstraZeneca, Vapotherm, Abbott, and Ophirex. Dr. Punches reports no financial relationships with commercial interests. Dr. Hudak reports no financial relationships with commercial interests. Dr. Pascual reports no financial relationships with commercial interests. Dr. Seamon reports no financial relationships with commercial interests. Dr. Harris reports no financial relationships with commercial interests. Dr. Pearson reports no financial relationships with commercial interests. Dr. Peak reports no financial relationships with commercial interests. Dr. Merchant reports no financial relationships with commercial interests. Dr. Domeier reports no financial relationships with commercial interests. Dr. O’Neil reports no financial relationships with commercial interests. Dr. Sergot reports no financial relationships with commercial interests. Dr. Sanchez reports no financial relationships with commercial interests. Dr. Bruce reports no financial relationships with commercial interests. Dr. Harte has no competing interest related to this work, though in the last three years he has received research funding from NIH, Aptinyx, and Arbor Medical Innovations, and consulting payments from Memorial Sloan Kettering Cancer Center, Wayne State University, Indiana University Indianapolis, The Ohio State University, Dana Farber Cancer Institute, and Stanford University. In the past 3 years, Dr. Kessler was a consultant for Cambridge Health Alliance, Canandaigua VA Medical Center, Holmusk, Partners Healthcare, Inc., RallyPoint Networks, Inc., and Sage Therapeutics. He has stock options in Cerebral Inc., Mirah, PYM, and Roga Sciences. Dr. Koenen has been a paid scientific consultant for the US Department of Justice and Covington Burling, LLP over the last three years. She receives royalties from Guilford Press and Oxford University Press. Dr. McLean has served as a consultant for Walter Reed Army Institute for Research, Arbor Medical Innovations, and BioXcel Therapeutics, Inc. Dr. An reports no financial relationships with commercial interests. The remaining authors have nothing to disclose.